Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis
Source abstract
Abstract
Tumour microenvironment greatly influences the development and metastasis of cancer progression. The development of three dimensional (3D) culture models which mimic that displayed in vivo can improve cancer biology studies and accelerate novel anticancer drug screening. Inspired by a systems biology approach, we have formed 3D in vitro bioengineered tumour angiogenesis microenvironments within a glycosaminoglycan-based hydrogel culture system. This microenvironment model can routinely recreate breast and prostate tumour vascularisation. The multiple cell types cultured within this model were less sensitive to chemotherapy when compared with two dimensional (2D) cultures, and displayed comparative tumour regression to that displayed in vivo. These features highlight the use of our in vitro culture model as a complementary testing platform in conjunction with animal models, addressing key reduction and replacement goals of the future. We anticipate that this biomimetic model will provide a platform for the in-depth analysis of cancer development and the discovery of novel therapeutic targets.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: 3D Printing in Biomedical Research · Cancer Cells and Metastasis · Cancer Research and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Putting tumours in context10.1038/35094059 ↗
2. Biomaterials offer cancer research the third dimension10.1038/nmat2619 ↗
3. Cell interactions with three-dimensional matrices10.1016/S0955-0674(02)00364-2 ↗
4. Local force and geometry sensing regulate cell functions10.1038/nrm1890 ↗
5. The hallmarks of cancer10.1016/S0092-8674(00)81683-9 ↗
6. Hallmarks of cancer: the next generation10.1016/j.cell.2011.02.013 ↗
7. Tissue-engineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery10.1016/j.addr.2014.05.006 ↗
8. A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis10.1371/journal.pone.0030753 ↗
9. Stromal fibroblasts are required for PC-3 human prostate cancer cells to produce capillary-like formation of endothelial cells in a three-dimensional co-culture system
10. A star-PEG-heparin hydrogel platform to aid cell replacement therapies for neurodegenerative diseases10.1016/j.biomaterials.2009.06.002 ↗
11. Defined polymer-peptide conjugates to form cell-instructive starPEG-heparin matrices in situ10.1002/adma.201300691 ↗
12. Glycosaminoglycan-based hydrogels to modulate heterocellular communication in in vitro angiogenesis models10.1038/srep04414 ↗
13. Improved method of human umbilical arterial endothelial cell culture10.1016/0049-3848(91)90245-R ↗
14. Mesenchymal stem cells can be differentiated into endothelial cells in vitro10.1634/stemcells.22-3-377 ↗
15. Tensile forces govern germ-layer organization in zebrafish10.1038/ncb1705 ↗
16. Calibration of atomic-force microscope tips10.1063/1.1143970 ↗
17. Engineering tumors with 3D scaffolds10.1038/nmeth1085 ↗
18. Experimental anti-tumor therapy in 3-D: spheroids–old hat or new challenge?10.1080/09553000701727531 ↗
19. Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody10.1158/1078-0432.CCR-08-2392 ↗
20. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts10.1186/1471-2407-5-2 ↗
21. Synthesis and biological evaluation of an albumin-binding prodrug of doxorubicin that is cleaved by prostate-specific antigen (PSA) in a PSA-positive orthotopic prostate carcinoma model (LNCaP)10.1002/ijc.23050 ↗
22. Nontoxic doses of suramin enhance activity of doxorubicin in prostate tumors10.1016/S0022-3565(24)29247-8 ↗
23. Angiogenesis in cancer and other diseases10.1038/35025220 ↗
24. Endothelial cells stimulate growth of normal and cancerous breast epithelial cells in 3D culture10.1186/1756-0500-3-184 ↗
25. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs10.1002/adma.201305506 ↗
26. In vitro angiogenesis induced by tumor-endothelial cell co-culture in bilayered, collagen I hydrogel bioengineered tumors10.1089/ten.tec.2012.0684 ↗
27. Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells10.1016/j.biomaterials.2010.07.064 ↗
28. Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment10.1371/journal.pone.0040217 ↗
29. The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer10.1016/j.addr.2014.01.001 ↗
30. Dominant effect of antiangiogenesis in combination therapy involving cyclophosphamide and axitinib10.1158/1078-0432.CCR-08-1174 ↗
31. Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin
32. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy10.1593/neo.12324 ↗
33. Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model10.3892/ol.2013.1515 ↗
34. Negative feedback for endothelial apoptosis: a potential physiological role for fibroblast growth factor10.1159/000111072 ↗
35. Simultaneous expression of cancer stem cell-like properties and cancer-associated fibroblast-like properties in a primary culture of breast cancer cells10.3390/cancers6031570 ↗
36. FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas10.1158/1078-0432.CCR-06-1164 ↗
37. Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression10.1002/mc.10146 ↗